Tailored HIV combination prevention services are accessible for key populations, including sex workers, men who have sex with men, people who inject drugs, transgender people and prisoners, as well as migrants

Key populations and their sexual partners account for 62% of new adult HIV infections globally, including a very high proportion of new HIV infections outside sub-Saharan Africa. They also experience higher prevalence of coinfections such as STIs, TB and viral hepatitis and while there has been some progress in adequately addressing key populations and their needs, legal and structural barriers, stigma and discrimination still hinder access to services.

Thus, the Joint Programme in 2020 continued to provide support to countries and communities, as well as led global policy and advocacy efforts to expand prevention among key populations, including innovative approaches for outreach, strategic information, and services provision in the evolving COVID-19 context in more than 130 countries. In this context, it worked on overcoming barriers in access to prevention and treatment services due to COVID-19, including reforms in service delivery, multi-month dispensing (MMD) of ART and opioid substitution therapy (OST), eliminating bureaucratic hurdles to service delivery, and greater reliance on and leveraging communities’ knowledge and their organizations as effective outreach and service providers.

Find more details in the SRA report.

Outputs 2016-2021

4.1Evidence-based HIV services for key populations implemented
4.2Comprehensive packages of harm reduction services established for people who inject drugs

 

OUTPUT INDICATORS

Targets and Milestones 2020 Progress
Percentage of countries with comprehensive packages of services for key populations defined and included in national strategies (Men who have sex with men, Sex workers)

2021: 90%

2019: 80%

2017: 70%

74% [64/87]

Percentage of countries with comprehensive packages of services for key populations defined and included in national strategies (Prisons and closed settings)

2021: 50%

2019: 35%

2017: 20%

57% [50/87]

Percentage of countries implementing in combination the most essential interventions to reduce new HIV infections among people who inject drugs

2021: 60%

2019: 50%

2017: 30%

63% [26/41]

Data source: 2020 JPMS country reports data. Final numbers may vary slightly.